CHIMERIC PROTEIN WITH HIGH ANTIMICROBIAL ACTIVITY

Researchers from CSIC have developed a chimeric protein (ClyRODI-H5) with an improved lytic activity against Staphylococcus sp. and higher stability than the parental endolysins of the state of the art. Thus, the invention relates to this chimeric protein and its use as an antimicrobial for treating and/or preventing staphylococcal infections without generation of resistant bacteria; for removing and/or preventing staphylococcal biofilms formation on abiotic surfaces, or for removing and/or preventing staphylococcal contamination of foods. Thus, the present invention belongs to the field of the treatment of bacterial contamination and/or infections.
Industrial partners or companies from the food or pharmaceutical field are being sought to collaborate through a patent license agreement.